Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Senft

Showing results (151-160 of 184) with videos related to

Pageof 19
Sort By:
Journal of Clinical Medicine|November 27, 2019
Regorafenib CSF Penetration, Efficacy, and MRI Patterns in Recurrent Malignant Glioma PatientsPia S Zeiner, Martina Kinzig, Iris Divé, et al.
Journal of Cancer Research and Clinical Oncology|September 12, 2023
Development and implementation of a student tumor board as a teaching format for medical studentsIrina Mäurer, Robert Drescher, Jakob Hammersen, et al.
Journal of Neuro-Oncology|May 2, 2024
Benchmarking palliative care practices in neurooncology: a german perspectiveAnna Cecilia Lawson McLean, Aaron Lawson McLean, Thomas Ernst, et al.
Acta Neuropathologica|May 9, 2019
Lack of H3K27 trimethylation is associated with 1p/19q codeletion in diffuse gliomasKatharina Filipski, Yannick Braun, Jenny Zinke, et al.
Plos One|March 21, 2014
Netrin-1 expression is an independent prognostic factor for poor patient survival in brain metastasesPatrick N Harter, Jenny Zinke, Alexander Scholz, et al.
Journal of Neuro-Oncology|March 20, 2024
Palliative care for in-patient malignant glioma patients in GermanyLarissa Fink, Birgitt van Oorschot, Christiane von Saß, et al.
Oncology Reports|October 18, 2017
Dabrafenib in patients with recurrent, BRAF V600E mutated malignant glioma and leptomeningeal diseaseMichael C Burger, Michael W Ronellenfitsch, Nadja I Lorenz, et al.
Epilepsia|October 19, 2016
Costs and cost-driving factors for acute treatment of adults with status epilepticus: A multicenter cohort study from GermanyLena-Marie Kortland, Anne Alfter, Oliver Bähr, et al.
Neuropathology and Applied Neurobiology|October 20, 2020
Linking epigenetic signature and metabolic phenotype in IDH mutant and IDH wildtype diffuse gliomaYannick Braun, Katharina Filipski, Simon Bernatz, et al.
Journal of Neurosurgery|February 16, 2022
Development and external validation of a clinical prediction model for survival in patients with IDH wild-type glioblastomaHendrik-Jan Mijderwijk, Daan Nieboer, Fatih Incekara, et al.
Pageof 19

Showing results (151-160 of 184) with videos related to

Sort By:
Pageof 19
Journal of Clinical Medicine|November 27, 2019
Regorafenib CSF Penetration, Efficacy, and MRI Patterns in Recurrent Malignant Glioma PatientsPia S Zeiner, Martina Kinzig, Iris Divé, et al.
Journal of Cancer Research and Clinical Oncology|September 12, 2023
Development and implementation of a student tumor board as a teaching format for medical studentsIrina Mäurer, Robert Drescher, Jakob Hammersen, et al.
Journal of Neuro-Oncology|May 2, 2024
Benchmarking palliative care practices in neurooncology: a german perspectiveAnna Cecilia Lawson McLean, Aaron Lawson McLean, Thomas Ernst, et al.
Acta Neuropathologica|May 9, 2019
Lack of H3K27 trimethylation is associated with 1p/19q codeletion in diffuse gliomasKatharina Filipski, Yannick Braun, Jenny Zinke, et al.
Plos One|March 21, 2014
Netrin-1 expression is an independent prognostic factor for poor patient survival in brain metastasesPatrick N Harter, Jenny Zinke, Alexander Scholz, et al.
Journal of Neuro-Oncology|March 20, 2024
Palliative care for in-patient malignant glioma patients in GermanyLarissa Fink, Birgitt van Oorschot, Christiane von Saß, et al.
Oncology Reports|October 18, 2017
Dabrafenib in patients with recurrent, BRAF V600E mutated malignant glioma and leptomeningeal diseaseMichael C Burger, Michael W Ronellenfitsch, Nadja I Lorenz, et al.
Epilepsia|October 19, 2016
Costs and cost-driving factors for acute treatment of adults with status epilepticus: A multicenter cohort study from GermanyLena-Marie Kortland, Anne Alfter, Oliver Bähr, et al.
Neuropathology and Applied Neurobiology|October 20, 2020
Linking epigenetic signature and metabolic phenotype in IDH mutant and IDH wildtype diffuse gliomaYannick Braun, Katharina Filipski, Simon Bernatz, et al.
Journal of Neurosurgery|February 16, 2022
Development and external validation of a clinical prediction model for survival in patients with IDH wild-type glioblastomaHendrik-Jan Mijderwijk, Daan Nieboer, Fatih Incekara, et al.
Pageof 19